Impax/Teva Wellbutrin SR Generic Cleared To Launch By Court, FDA
Executive Summary
Impax' bupropion sustained-release generic is cleared for launch following an appeals court ruling that the company does not infringe GlaxoSmithKline's Wellbutrin SR/Zyban patent